# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-25-017640
Filing Date
2025-10-09
Accepted
2025-10-09 17:15:26
Documents
20
Period of Report
2025-10-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | formpre14a.htm iXBRL | PRE 14A | 537702
2 | GRAPHIC | formpre14a_001.jpg | GRAPHIC | 113467
3 | GRAPHIC | formpre14a_002.jpg | GRAPHIC | 56498
4 | GRAPHIC | proxy_001.jpg | GRAPHIC | 319391
5 | GRAPHIC | proxy_002.jpg | GRAPHIC | 238285
| Complete submission text file | 0001493152-25-017640.txt |  | 2951703

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | bmra-20250531.xsd | EX-101.SCH | 5071
7 | XBRL DEFINITION FILE | bmra-20250531_def.xml | EX-101.DEF | 9172
8 | XBRL LABEL FILE | bmra-20250531_lab.xml | EX-101.LAB | 61622
9 | XBRL PRESENTATION FILE | bmra-20250531_pre.xml | EX-101.PRE | 43526
22 | EXTRACTED XBRL INSTANCE DOCUMENT | formpre14a_htm.xml | XML | 99431

Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: PRE 14A | Act: 34 | File No.: 001-37863 | Film No.: 251385845
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)